Oryzon to invest eur 20 million to develop new drugs
Catalan Economy
10 Sep 2009
Biotech company oryzon genomics has announced a four-year program to invest eur 20 million in the development of new drugs. oryzon ceo carlos buesa indicated that the company would use the resources to strengthen its research on biomarkers and antibody therapy.
oryzon recently opened its new 2,300-square-meter corporate headquarters in cornellà de llobregat (barcelona), with an investment of eur 2.5 million. the company expects revenue of eur 8 million for its current fiscal year.
source: expansión catalunya, 08/09/09
Related News and Success stories.
-
02 Mar 2026
See more Catalonia ranks 8th globally for attracting tech and digital foreign investment projectsCatalonia ranks 8th globally for attracting tech and digital foreign investment projects
-
26 Feb 2026
See more Catalonia’s packaging industry reaches €12.2 billion with 855 companies and a strong global presenceCatalonia’s packaging industry reaches €12.2 billion with 855 companies and a strong global presence
-
24 Feb 2026
See more Catalan Exhibitors at Mobile World Congress 2026Catalan Exhibitors at Mobile World Congress 2026
-
23 Feb 2026
See more The number of startups in Catalonia hits 2,403 in 2025, 5.2% over the previous year, and the highest figure on recordThe number of startups in Catalonia hits 2,403 in 2025, 5.2% over the previous year, and the highest figure on record
